ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Charlotte, NC, USA:

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

This is a phase II study using risk and response-adapted therapy for low, intermediate and high risk classical Hodgkin lymphoma. Chemotherap...

Enrolling
Hodgkin Lymphoma
Drug: Etoposide
Drug: DTIC

Phase 2

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Charlotte, North Carolina, United States and 7 other locations

The purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma...

Enrolling
Lymphoma
Solid Tumors
Drug: Chemotherapy
Drug: Eflapegrastim

Phase 2

Spectrum Pharmaceuticals
Spectrum Pharmaceuticals

Charlotte, North Carolina, United States and 3 other locations

dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the rec...

Enrolling
Mantle Cell Lymphoma
Relapsed Mantle Cell Lymphoma
Drug: BGB-11417

Phase 1, Phase 2

BeiGene
BeiGene

Charlotte, North Carolina, United States and 73 other locations

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: brentuximab vedotin
Drug: bleomycin

Phase 3

Takeda
Takeda

Charlotte, North Carolina, United States and 215 other locations

with acute lymphoblastic leukemia (ALL) and acute lymphoblastic lymphoma (LLy).Primary Therapeutic Objectives:* To improve the event-free su...

Active, not recruiting
Acute Lymphoblastic Lymphoma
Acute Lymphoblastic Leukemia
Drug: Asparaginase Erwinia chrysanthemi (recombinant)-rywn
Drug: Thioguanine

Phase 2, Phase 3

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Charlotte, North Carolina, United States and 7 other locations

with various types of blood cancers:* relapsed or refractory (R/R) lymphoma* multiple myeloma* newly diagnosed acute myeloid leukemia (AML)....

Active, not recruiting
Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Dexamethasone
Drug: Venetoclax

Phase 1

Pfizer
Pfizer

Charlotte, North Carolina, United States and 61 other locations

dose escalation and expansion clinical trial to evaluate the safety, tolerability and PK of HMPL-689 in patients with relapsed or refractory lymphomas...

Active, not recruiting
Lymphoma
Drug: HMPL-689

Phase 1

HUTCHMED
HUTCHMED

Charlotte, North Carolina, United States and 26 other locations

pharmacokinetic profile of GRC54276 alone and in combination with pembrolizumab or atezolizumab in participants with advanced solid tumors and lymphomas...

Enrolling
Lymphoma
Advanced Solid Tumor
Drug: GRC 54276 + Pembrolizumab
Drug: GRC 54276 + Atezolizumab

Phase 1

Glenmark Pharmaceuticals

Huntersville, North Carolina, United States and 17 other locations

This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Fludarabine
Drug: JCAR017

Phase 2

Celgene
Celgene

Charlotte, North Carolina, United States and 37 other locations

The primary objective of Stage 1 is to evaluate the safety of nivolumab consolidation after completion of HD-MTX containing induction chemotherapy in...

Active, not recruiting
Eye and Orbit
Brain and Nervous System
Drug: Nivolumab

Phase 1

Wake Forest University (WFU)
Wake Forest University (WFU)

Charlotte, North Carolina, United States and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems